Two Sigma Advisers’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9M | Buy |
+1,091,428
| New | +$28.9M | 0.06% | 266 |
|
|
2023
Q4 | – | Sell |
-10,628
| Closed | -$118K | – | 2656 |
|
|
2023
Q3 | $118K | Buy |
+10,628
| New | +$118K | ﹤0.01% | 2191 |
|
|
2023
Q2 | – | Sell |
-896,528
| Closed | -$14.9M | – | 2675 |
|
|
2023
Q1 | $14.9M | Sell |
896,528
-50,500
| -5% | -$841K | 0.04% | 413 |
|
|
2022
Q4 | $8.9M | Buy |
947,028
+40,400
| +4% | +$380K | 0.02% | 550 |
|
|
2022
Q3 | $2.47M | Sell |
906,628
-214,400
| -19% | -$583K | 0.01% | 1064 |
|
|
2022
Q2 | $3.24M | Buy |
1,121,028
+13,000
| +1% | +$37.6K | 0.01% | 966 |
|
|
2022
Q1 | $3.32M | Buy |
1,108,028
+229,600
| +26% | +$689K | 0.01% | 991 |
|
|
2021
Q4 | $4.04M | Sell |
878,428
-60,400
| -6% | -$278K | 0.01% | 860 |
|
|
2021
Q3 | $5.9M | Sell |
938,828
-45,400
| -5% | -$285K | 0.02% | 710 |
|
|
2021
Q2 | $5.9M | Sell |
984,228
-42,000
| -4% | -$252K | 0.02% | 788 |
|
|
2021
Q1 | $6.49M | Buy |
1,026,228
+562,700
| +121% | +$3.56M | 0.02% | 749 |
|
|
2020
Q4 | $2.61M | Buy |
463,528
+382,000
| +469% | +$2.15M | 0.01% | 1126 |
|
|
2020
Q3 | $474K | Buy |
81,528
+42,028
| +106% | +$244K | ﹤0.01% | 1848 |
|
|
2020
Q2 | $285K | Buy |
+39,500
| New | +$285K | ﹤0.01% | 2137 |
|
|
2019
Q1 | – | Sell |
-13,400
| Closed | -$103K | – | 2464 |
|
|
2018
Q4 | $103K | Sell |
13,400
-18,800
| -58% | -$145K | ﹤0.01% | 2219 |
|
|
2018
Q3 | $561K | Buy |
32,200
+8,000
| +33% | +$139K | ﹤0.01% | 1750 |
|
|
2018
Q2 | $230K | Buy |
24,200
+5,400
| +29% | +$51.3K | ﹤0.01% | 2174 |
|
|
2018
Q1 | $82K | Buy |
+18,800
| New | +$82K | ﹤0.01% | 2236 |
|